Chapter 6
Crossing the Carbon Bridge: First Steps and New Questions
The ethics board approves the first-in-human trial of the 3D Carbon Nanotube-Fullerene Hyper-Lattice. Marcus Bellweather undergoes the procedure, supported by Dr. Thorne and Dr. Hanson. The surgery proceeds with careful monitoring, and early signs suggest function where there was none before. The team reflects on the milestone, acknowledges the uncertainties that remain, and looks to the future of spinal cord repair.
Late in the evening, the notification lingered on the lab screen. Dr. Lena Hanson clicked it open. The board’s verdict arrived in a few clipped paragraphs: Approval granted, with enhanced monitoring, full transparency, and continued ethics oversight. The project could proceed—first in-human trial authorized.
Word traveled quickly. Dr. Thorne reread the decision, his shoulders slackening in relief. Marcus Bellweather learned the news from a simple call—no grand pronouncements, just Hanson’s steady assurance: "We move forward, Marcus. If you’re still ready." Marcus answered with the briefest pause. "Let’s do it."
Preparation was meticulous. The surgery would be performed in a university hospital suite, with the research team present but the operation led by experienced neurosurgeons. Marcus underwent final imaging and baseline assessments. Hanson triple-checked every protocol, from sterilization routines to post-op contingency plans. When the day arrived, the air in the prep room was tense but purposeful.
Keep reading "Crossing the Carbon Bridge: First Steps and New Questions"
Open the same story in AIBookCraft. Later chapters may require an active subscription.
Free on iOS & Android · No signup to read